On September 17, TG Therapeutics rose 5.4% in regular trading, trading at $56.19 USD/share, with turnover of $63.36 million.
Within the Biotechnology sector where TG Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, Moderna up 2.15%, Gilead Sciences up 1.70%, Amgen up 0.53%, AbbVie up 0.27%, Revolution Medicines down 2.92%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)